United StatesBreaking News

ZIM (NYSE:ZIM) announced an operational update regarding its pending business combination, confirming it remains in compliance with its merger agreement alongside Hapag-Lloyd.

The Middleby Corporation (NASDAQ:MIDD) said it has completed the previously announced spin-off of its Food Processing business into a new standalone company, Midera Food Processing.

Antelope Enterprise Holdings (NASDAQ:AEHL) reported unaudited results for the six months ended March 31, 2026, showing revenue of approximately $29.9 million.

Invivyd (NASDAQ:IVVD) announced it received formal notification from the FDA that the Emergency Use Authorization for its monoclonal antibody treatment PEMGARDA will terminate on June 29, 2027.

Morgan Stanley Chief US Equity Strategist Mike Wilson says investors are rotating out of some of the year's biggest winning technology trades. He says hyperscalers will stabilize and semiconductors stocks will correct. He speaks on "Bloomberg Surveillance."

Innovative Eyewear (NASDAQ:LUCY) reported preliminary unaudited net sales of approximately $0.99 million for Q2 2026, representing a year-over-year increase of about 71%.

Ondas Holdings (NASDAQ:ONDS) said it has entered into an agreement to acquire DZYNE Technologies in a transaction valued at approximately $875.8 million in cash and stock.

Kelsey Berro, Fixed Income Portfolio Manager at JPMorgan Asset Management, discussed the Federal Reserve's monetary policy outlook, indicating that a rate hike in July is probably off the table and she expects the Fed to stay on hold for the year. Berro also says while the recent payrolls report suggests the labor market is stable, it's not going to decisively influence Fed decisions. She speaks on "Bloomberg Surveillance."

Iridium (NASDAQ:IRDM) announced it completed the acquisition of Aireon to combine global satellite communications with space-based air traffic surveillance.

easyJet said it has agreed in principle to a £5.5 billion ($7.3 billion) cash offer from U.S. investment firm Castlelake after rejecting four earlier proposals.

Agenus (NASDAQ:AGEN) reported updated Phase 1b clinical data for its botensilimab (BOT) and balstilimab (BAL) combination in patients with refractory microsatellite-stable metastatic colorectal cancer without active liver metastases.

Solaris Energy Infrastructure (NYSE:SEI) announced it executed an agreement to acquire Global Energy Services Alliance to scale up its full-cycle power generation solutions.